I believe Cap, in 2014, addressed the confrontational relationship(unavoidable and toxic) the Lab has with our coworkers concerning hemolysis and potential risks, to patients, and overall negative experience.
I believe Cap released recommendations taking the automatic redraw the Lab endorses and placing it in the doctor's hands.
A patient having a stroke, moderate hemolysis, values released with comments stating hemolysis with recommendations, but the decision is solely the doctor's. The doctor may need to establish kidney function for CT.
Large hospitals have LIS post comments and release values taking it completely out of tech hands avoiding non-compliance at the bench level.
The difference this makes is felt throughout.
The pushback can be overwhelming.
Derek Hardwick MLT ASCP
------------------------------
Derek Hardwick Technician (eg MLT, HT, PBT, DPT)
Irmo SC
(843)506-2304
------------------------------
Original Message:
Sent: 04-24-2024 17:48
From: Angela Tomei Robinson
Subject: Hemolysis, Icterus, and Lipemia Interference: New Approaches to Old Foes | clinicallab
https://www.clinicallab.com/hemolysis-icterus-and-lipemia-interference-new-approaches-to-old-foes-26664
Sent from my Verizon, Samsung Galaxy smartphone